A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators.
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Conference 11.01.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed